Loading…

DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection

Hepatocellular carcinoma (HCC) is a common malignancy with a dismal prognosis. It is of great importance to identify biomarkers for the prediction of patients' survival.The mRNA expression level of deoxyribonuclease 1 like 3 (DNASE1L3) and its correlation with survival were accessed in 424 samp...

Full description

Saved in:
Bibliographic Details
Published in:Aging (Albany, NY.) NY.), 2020-01, Vol.12 (2), p.1171-1185
Main Authors: Wang, Shuncong, Ma, Haiqing, Li, Xuemin, Mo, Xiangqiong, Zhang, Haiyu, Yang, Lewei, Deng, Yun, Yan, Yan, Yang, Guangwei, Liu, Xingwei, Sun, Huanhuan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c387t-4f0a090c00919827288dd20e8e5349d67f2a6cf7715276c63aadd0ee2482e84b3
cites cdi_FETCH-LOGICAL-c387t-4f0a090c00919827288dd20e8e5349d67f2a6cf7715276c63aadd0ee2482e84b3
container_end_page 1185
container_issue 2
container_start_page 1171
container_title Aging (Albany, NY.)
container_volume 12
creator Wang, Shuncong
Ma, Haiqing
Li, Xuemin
Mo, Xiangqiong
Zhang, Haiyu
Yang, Lewei
Deng, Yun
Yan, Yan
Yang, Guangwei
Liu, Xingwei
Sun, Huanhuan
description Hepatocellular carcinoma (HCC) is a common malignancy with a dismal prognosis. It is of great importance to identify biomarkers for the prediction of patients' survival.The mRNA expression level of deoxyribonuclease 1 like 3 (DNASE1L3) and its correlation with survival were accessed in 424 samples from The Cancer Genome Atlas database. Its expression level was confirmed by real-time quantitative polymerase chain reaction and western blotting in 20 pairs of postsurgical specimens. In addition, immunohistochemistry staining of DNASE1L3 was also performed in 113 postoperative samples, using a histochemistry score system. The relationship between patients' survival and DNASE1L3 expression level was evaluated by the Kaplan-Meier method.DNASE1L3 is downregulated in both mRNA and protein levels in HCC tissues, compared with adjacent normal tissues. 52 of 113 HCC specimens showed positive DNASE1L3 protein expression. Patients with positive DNASE1L3 expression had significantly longer overall survival, compared with patients with negative expression ( = 0.023). However, the DNASE1L3 fails to discriminate progression-free survival ( = 0.134). Multivariate COX analysis revealed that positive DNASE1L3 expression and higher differentiation were significantly associated with better overall survival.This study demonstrated that positive DNASE1L3 expression is an independent prognostic factor for better survival in HCC patients following radical resection.
doi_str_mv 10.18632/aging.102675
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7053625</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2345508792</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-4f0a090c00919827288dd20e8e5349d67f2a6cf7715276c63aadd0ee2482e84b3</originalsourceid><addsrcrecordid>eNpVkUlPwzAQhS0EgrIcuSIfuQS8xEsuSFVZpQoOwNmaOk4xcuNiJ0X8ewKFCk4zmvn05o0eQseUnFEtOTuHuW_nZ5QwqcQWGtGqFEUpdLX9p99D-zm_EiKFKOUu2uO0UopTPULzy_vx4xWdcgwZQ4t9W3sLXUw4NriBVUwwCw7nPq38CsKwxy9uOQDWhdAHSNhCsr6NC8DD2Lu2y7iJIcT3wRZOLjvb-dgeop0GQnZHP_UAPV9fPU1ui-nDzd1kPC0s16oryoYAqYglpKKVZoppXdeMOO0EL6taqoaBtI1SVDAlreQAdU2cY6VmTpczfoAu1rrLfrZwtR38JAhmmfwC0oeJ4M3_TetfzDyujCKCSyYGgdMfgRTfepc7s_D561loXeyzYbwUgmhVsQEt1qhNMefkms0ZSsx3OOY7HLMOZ-BP_nrb0L9p8E95-Y1W</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2345508792</pqid></control><display><type>article</type><title>DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection</title><source>PubMed Central</source><creator>Wang, Shuncong ; Ma, Haiqing ; Li, Xuemin ; Mo, Xiangqiong ; Zhang, Haiyu ; Yang, Lewei ; Deng, Yun ; Yan, Yan ; Yang, Guangwei ; Liu, Xingwei ; Sun, Huanhuan</creator><creatorcontrib>Wang, Shuncong ; Ma, Haiqing ; Li, Xuemin ; Mo, Xiangqiong ; Zhang, Haiyu ; Yang, Lewei ; Deng, Yun ; Yan, Yan ; Yang, Guangwei ; Liu, Xingwei ; Sun, Huanhuan</creatorcontrib><description>Hepatocellular carcinoma (HCC) is a common malignancy with a dismal prognosis. It is of great importance to identify biomarkers for the prediction of patients' survival.The mRNA expression level of deoxyribonuclease 1 like 3 (DNASE1L3) and its correlation with survival were accessed in 424 samples from The Cancer Genome Atlas database. Its expression level was confirmed by real-time quantitative polymerase chain reaction and western blotting in 20 pairs of postsurgical specimens. In addition, immunohistochemistry staining of DNASE1L3 was also performed in 113 postoperative samples, using a histochemistry score system. The relationship between patients' survival and DNASE1L3 expression level was evaluated by the Kaplan-Meier method.DNASE1L3 is downregulated in both mRNA and protein levels in HCC tissues, compared with adjacent normal tissues. 52 of 113 HCC specimens showed positive DNASE1L3 protein expression. Patients with positive DNASE1L3 expression had significantly longer overall survival, compared with patients with negative expression ( = 0.023). However, the DNASE1L3 fails to discriminate progression-free survival ( = 0.134). Multivariate COX analysis revealed that positive DNASE1L3 expression and higher differentiation were significantly associated with better overall survival.This study demonstrated that positive DNASE1L3 expression is an independent prognostic factor for better survival in HCC patients following radical resection.</description><identifier>ISSN: 1945-4589</identifier><identifier>EISSN: 1945-4589</identifier><identifier>DOI: 10.18632/aging.102675</identifier><identifier>PMID: 31977318</identifier><language>eng</language><publisher>United States: Impact Journals</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor ; Carcinoma, Hepatocellular - genetics ; Carcinoma, Hepatocellular - mortality ; Carcinoma, Hepatocellular - pathology ; Carcinoma, Hepatocellular - surgery ; Computational Biology - methods ; Endodeoxyribonucleases - genetics ; Female ; Gene Expression Regulation, Neoplastic ; Hepatectomy ; Humans ; Immunohistochemistry ; Liver Neoplasms - genetics ; Liver Neoplasms - mortality ; Liver Neoplasms - pathology ; Liver Neoplasms - surgery ; Male ; Middle Aged ; Prognosis ; Reproducibility of Results ; Research Paper ; Survival Analysis ; Transcriptome ; Tumor Burden</subject><ispartof>Aging (Albany, NY.), 2020-01, Vol.12 (2), p.1171-1185</ispartof><rights>Copyright © 2020 Wang et al.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-4f0a090c00919827288dd20e8e5349d67f2a6cf7715276c63aadd0ee2482e84b3</citedby><cites>FETCH-LOGICAL-c387t-4f0a090c00919827288dd20e8e5349d67f2a6cf7715276c63aadd0ee2482e84b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053625/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053625/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31977318$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Shuncong</creatorcontrib><creatorcontrib>Ma, Haiqing</creatorcontrib><creatorcontrib>Li, Xuemin</creatorcontrib><creatorcontrib>Mo, Xiangqiong</creatorcontrib><creatorcontrib>Zhang, Haiyu</creatorcontrib><creatorcontrib>Yang, Lewei</creatorcontrib><creatorcontrib>Deng, Yun</creatorcontrib><creatorcontrib>Yan, Yan</creatorcontrib><creatorcontrib>Yang, Guangwei</creatorcontrib><creatorcontrib>Liu, Xingwei</creatorcontrib><creatorcontrib>Sun, Huanhuan</creatorcontrib><title>DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection</title><title>Aging (Albany, NY.)</title><addtitle>Aging (Albany NY)</addtitle><description>Hepatocellular carcinoma (HCC) is a common malignancy with a dismal prognosis. It is of great importance to identify biomarkers for the prediction of patients' survival.The mRNA expression level of deoxyribonuclease 1 like 3 (DNASE1L3) and its correlation with survival were accessed in 424 samples from The Cancer Genome Atlas database. Its expression level was confirmed by real-time quantitative polymerase chain reaction and western blotting in 20 pairs of postsurgical specimens. In addition, immunohistochemistry staining of DNASE1L3 was also performed in 113 postoperative samples, using a histochemistry score system. The relationship between patients' survival and DNASE1L3 expression level was evaluated by the Kaplan-Meier method.DNASE1L3 is downregulated in both mRNA and protein levels in HCC tissues, compared with adjacent normal tissues. 52 of 113 HCC specimens showed positive DNASE1L3 protein expression. Patients with positive DNASE1L3 expression had significantly longer overall survival, compared with patients with negative expression ( = 0.023). However, the DNASE1L3 fails to discriminate progression-free survival ( = 0.134). Multivariate COX analysis revealed that positive DNASE1L3 expression and higher differentiation were significantly associated with better overall survival.This study demonstrated that positive DNASE1L3 expression is an independent prognostic factor for better survival in HCC patients following radical resection.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers, Tumor</subject><subject>Carcinoma, Hepatocellular - genetics</subject><subject>Carcinoma, Hepatocellular - mortality</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Carcinoma, Hepatocellular - surgery</subject><subject>Computational Biology - methods</subject><subject>Endodeoxyribonucleases - genetics</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Hepatectomy</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Liver Neoplasms - genetics</subject><subject>Liver Neoplasms - mortality</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - surgery</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Reproducibility of Results</subject><subject>Research Paper</subject><subject>Survival Analysis</subject><subject>Transcriptome</subject><subject>Tumor Burden</subject><issn>1945-4589</issn><issn>1945-4589</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkUlPwzAQhS0EgrIcuSIfuQS8xEsuSFVZpQoOwNmaOk4xcuNiJ0X8ewKFCk4zmvn05o0eQseUnFEtOTuHuW_nZ5QwqcQWGtGqFEUpdLX9p99D-zm_EiKFKOUu2uO0UopTPULzy_vx4xWdcgwZQ4t9W3sLXUw4NriBVUwwCw7nPq38CsKwxy9uOQDWhdAHSNhCsr6NC8DD2Lu2y7iJIcT3wRZOLjvb-dgeop0GQnZHP_UAPV9fPU1ui-nDzd1kPC0s16oryoYAqYglpKKVZoppXdeMOO0EL6taqoaBtI1SVDAlreQAdU2cY6VmTpczfoAu1rrLfrZwtR38JAhmmfwC0oeJ4M3_TetfzDyujCKCSyYGgdMfgRTfepc7s_D561loXeyzYbwUgmhVsQEt1qhNMefkms0ZSsx3OOY7HLMOZ-BP_nrb0L9p8E95-Y1W</recordid><startdate>20200124</startdate><enddate>20200124</enddate><creator>Wang, Shuncong</creator><creator>Ma, Haiqing</creator><creator>Li, Xuemin</creator><creator>Mo, Xiangqiong</creator><creator>Zhang, Haiyu</creator><creator>Yang, Lewei</creator><creator>Deng, Yun</creator><creator>Yan, Yan</creator><creator>Yang, Guangwei</creator><creator>Liu, Xingwei</creator><creator>Sun, Huanhuan</creator><general>Impact Journals</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200124</creationdate><title>DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection</title><author>Wang, Shuncong ; Ma, Haiqing ; Li, Xuemin ; Mo, Xiangqiong ; Zhang, Haiyu ; Yang, Lewei ; Deng, Yun ; Yan, Yan ; Yang, Guangwei ; Liu, Xingwei ; Sun, Huanhuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-4f0a090c00919827288dd20e8e5349d67f2a6cf7715276c63aadd0ee2482e84b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers, Tumor</topic><topic>Carcinoma, Hepatocellular - genetics</topic><topic>Carcinoma, Hepatocellular - mortality</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Carcinoma, Hepatocellular - surgery</topic><topic>Computational Biology - methods</topic><topic>Endodeoxyribonucleases - genetics</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Hepatectomy</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Liver Neoplasms - genetics</topic><topic>Liver Neoplasms - mortality</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - surgery</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Reproducibility of Results</topic><topic>Research Paper</topic><topic>Survival Analysis</topic><topic>Transcriptome</topic><topic>Tumor Burden</topic><toplevel>online_resources</toplevel><creatorcontrib>Wang, Shuncong</creatorcontrib><creatorcontrib>Ma, Haiqing</creatorcontrib><creatorcontrib>Li, Xuemin</creatorcontrib><creatorcontrib>Mo, Xiangqiong</creatorcontrib><creatorcontrib>Zhang, Haiyu</creatorcontrib><creatorcontrib>Yang, Lewei</creatorcontrib><creatorcontrib>Deng, Yun</creatorcontrib><creatorcontrib>Yan, Yan</creatorcontrib><creatorcontrib>Yang, Guangwei</creatorcontrib><creatorcontrib>Liu, Xingwei</creatorcontrib><creatorcontrib>Sun, Huanhuan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Aging (Albany, NY.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Shuncong</au><au>Ma, Haiqing</au><au>Li, Xuemin</au><au>Mo, Xiangqiong</au><au>Zhang, Haiyu</au><au>Yang, Lewei</au><au>Deng, Yun</au><au>Yan, Yan</au><au>Yang, Guangwei</au><au>Liu, Xingwei</au><au>Sun, Huanhuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection</atitle><jtitle>Aging (Albany, NY.)</jtitle><addtitle>Aging (Albany NY)</addtitle><date>2020-01-24</date><risdate>2020</risdate><volume>12</volume><issue>2</issue><spage>1171</spage><epage>1185</epage><pages>1171-1185</pages><issn>1945-4589</issn><eissn>1945-4589</eissn><abstract>Hepatocellular carcinoma (HCC) is a common malignancy with a dismal prognosis. It is of great importance to identify biomarkers for the prediction of patients' survival.The mRNA expression level of deoxyribonuclease 1 like 3 (DNASE1L3) and its correlation with survival were accessed in 424 samples from The Cancer Genome Atlas database. Its expression level was confirmed by real-time quantitative polymerase chain reaction and western blotting in 20 pairs of postsurgical specimens. In addition, immunohistochemistry staining of DNASE1L3 was also performed in 113 postoperative samples, using a histochemistry score system. The relationship between patients' survival and DNASE1L3 expression level was evaluated by the Kaplan-Meier method.DNASE1L3 is downregulated in both mRNA and protein levels in HCC tissues, compared with adjacent normal tissues. 52 of 113 HCC specimens showed positive DNASE1L3 protein expression. Patients with positive DNASE1L3 expression had significantly longer overall survival, compared with patients with negative expression ( = 0.023). However, the DNASE1L3 fails to discriminate progression-free survival ( = 0.134). Multivariate COX analysis revealed that positive DNASE1L3 expression and higher differentiation were significantly associated with better overall survival.This study demonstrated that positive DNASE1L3 expression is an independent prognostic factor for better survival in HCC patients following radical resection.</abstract><cop>United States</cop><pub>Impact Journals</pub><pmid>31977318</pmid><doi>10.18632/aging.102675</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1945-4589
ispartof Aging (Albany, NY.), 2020-01, Vol.12 (2), p.1171-1185
issn 1945-4589
1945-4589
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7053625
source PubMed Central
subjects Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Carcinoma, Hepatocellular - genetics
Carcinoma, Hepatocellular - mortality
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - surgery
Computational Biology - methods
Endodeoxyribonucleases - genetics
Female
Gene Expression Regulation, Neoplastic
Hepatectomy
Humans
Immunohistochemistry
Liver Neoplasms - genetics
Liver Neoplasms - mortality
Liver Neoplasms - pathology
Liver Neoplasms - surgery
Male
Middle Aged
Prognosis
Reproducibility of Results
Research Paper
Survival Analysis
Transcriptome
Tumor Burden
title DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A50%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DNASE1L3%20as%20an%20indicator%20of%20favorable%20survival%20in%20hepatocellular%20carcinoma%20patients%20following%20resection&rft.jtitle=Aging%20(Albany,%20NY.)&rft.au=Wang,%20Shuncong&rft.date=2020-01-24&rft.volume=12&rft.issue=2&rft.spage=1171&rft.epage=1185&rft.pages=1171-1185&rft.issn=1945-4589&rft.eissn=1945-4589&rft_id=info:doi/10.18632/aging.102675&rft_dat=%3Cproquest_pubme%3E2345508792%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c387t-4f0a090c00919827288dd20e8e5349d67f2a6cf7715276c63aadd0ee2482e84b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2345508792&rft_id=info:pmid/31977318&rfr_iscdi=true